Annual EBITDA:
-$269.00M+$22.00M(+7.56%)Summary
- As of today, RCUS annual EBITDA is -$269.00 million, with the most recent change of +$22.00 million (+7.56%) on December 31, 2024.
- During the last 3 years, RCUS annual EBITDA has fallen by -$328.00 million (-555.93%).
- RCUS annual EBITDA is now -555.93% below its all-time high of $59.00 million, reached on December 31, 2021.
Performance
RCUS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$4.00M+$112.00M(+103.70%)Summary
- As of today, RCUS quarterly EBITDA is $4.00 million, with the most recent change of +$112.00 million (+103.70%) on June 30, 2025.
- Over the past year, RCUS quarterly EBITDA has increased by +$95.00 million (+104.40%).
- RCUS quarterly EBITDA is now -98.59% below its all-time high of $282.95 million, reached on December 31, 2021.
Performance
RCUS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$282.00M+$95.00M(+25.20%)Summary
- As of today, RCUS TTM EBITDA is -$282.00 million, with the most recent change of +$95.00 million (+25.20%) on June 30, 2025.
- Over the past year, RCUS TTM EBITDA has dropped by -$47.00 million (-20.00%).
- RCUS TTM EBITDA is now -413.49% below its all-time high of $89.95 million, reached on September 30, 2022.
Performance
RCUS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RCUS EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | +7.6% | +104.4% | -20.0% |
3Y3 Years | -555.9% | +106.3% | -471.3% |
5Y5 Years | -231.6% | +109.0% | -244.0% |
RCUS EBITDA Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | -555.9% | +7.6% | at high | +103.7% | -413.5% | +25.2% |
5Y | 5-Year | -555.9% | +7.6% | -98.6% | +103.7% | -413.5% | +25.2% |
All-Time | All-Time | -555.9% | +7.6% | -98.6% | +103.7% | -413.5% | +25.2% |
RCUS EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $4.00M(+103.7%) | -$282.00M(+25.2%) |
Mar 2025 | - | -$108.00M(-21.3%) | -$377.00M(-40.1%) |
Dec 2024 | -$269.00M(+7.6%) | -$89.00M(0.0%) | -$269.00M(-4.7%) |
Sep 2024 | - | -$89.00M(+2.2%) | -$257.00M(-9.4%) |
Jun 2024 | - | -$91.00M(>-9900.0%) | -$235.00M(-8.8%) |
Mar 2024 | - | $0.00(+100.0%) | -$216.00M(+25.8%) |
Dec 2023 | -$291.00M(-12.8%) | -$77.00M(-14.9%) | -$291.00M(-4.3%) |
Sep 2023 | - | -$67.00M(+6.9%) | -$279.00M(-1.5%) |
Jun 2023 | - | -$72.00M(+4.0%) | -$275.00M(-3.0%) |
Mar 2023 | - | -$75.00M(-15.4%) | -$267.00M(-3.5%) |
Dec 2022 | -$258.00M(-537.3%) | -$65.00M(-3.2%) | -$258.00M(-386.8%) |
Sep 2022 | - | -$63.00M(+1.6%) | $89.95M(+18.5%) |
Jun 2022 | - | -$64.00M(+3.0%) | $75.94M(+17.2%) |
Mar 2022 | - | -$66.00M(-123.3%) | $64.79M(+9.8%) |
Dec 2021 | $59.00M | $282.95M(+467.4%) | $59.00M(+121.5%) |
Sep 2021 | - | -$77.01M(-2.5%) | -$274.65M(-40.8%) |
Jun 2021 | - | -$75.15M(-4.7%) | -$195.09M(-18.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2021 | - | -$71.79M(-41.6%) | -$164.38M(-37.0%) |
Dec 2020 | -$120.00M(-47.9%) | -$50.70M(-2086.7%) | -$120.00M(-46.4%) |
Sep 2020 | - | $2.55M(+105.7%) | -$81.97M(+23.3%) |
Jun 2020 | - | -$44.44M(-62.1%) | -$106.89M(-17.8%) |
Mar 2020 | - | -$27.41M(-116.3%) | -$90.73M(-11.8%) |
Dec 2019 | -$81.13M(-58.5%) | -$12.67M(+43.3%) | -$81.13M(-0.2%) |
Sep 2019 | - | -$22.36M(+20.9%) | -$81.00M(-16.0%) |
Jun 2019 | - | -$28.28M(-58.7%) | -$69.81M(-23.5%) |
Mar 2019 | - | -$17.82M(-42.1%) | -$56.51M(-10.4%) |
Dec 2018 | -$51.20M(-0.7%) | -$12.54M(-12.2%) | -$51.20M(+0.1%) |
Sep 2018 | - | -$11.17M(+25.4%) | -$51.24M(+18.0%) |
Jun 2018 | - | -$14.98M(-19.8%) | -$62.47M(-10.5%) |
Mar 2018 | - | -$12.50M(+0.6%) | -$56.52M(-11.2%) |
Dec 2017 | -$50.83M(-201.3%) | -$12.58M(+43.9%) | -$50.83M(-32.9%) |
Sep 2017 | - | -$22.40M(-147.9%) | -$38.25M(-141.3%) |
Jun 2017 | - | -$9.04M(-32.6%) | -$15.85M(-132.6%) |
Mar 2017 | - | -$6.81M | -$6.81M |
Dec 2016 | -$16.87M | - | - |
FAQ
- What is Arcus Biosciences, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. annual EBITDA year-on-year change?
- What is Arcus Biosciences, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. quarterly EBITDA year-on-year change?
- What is Arcus Biosciences, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. TTM EBITDA year-on-year change?
What is Arcus Biosciences, Inc. annual EBITDA?
The current annual EBITDA of RCUS is -$269.00M
What is the all-time high annual EBITDA for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high annual EBITDA is $59.00M
What is Arcus Biosciences, Inc. annual EBITDA year-on-year change?
Over the past year, RCUS annual EBITDA has changed by +$22.00M (+7.56%)
What is Arcus Biosciences, Inc. quarterly EBITDA?
The current quarterly EBITDA of RCUS is $4.00M
What is the all-time high quarterly EBITDA for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high quarterly EBITDA is $282.95M
What is Arcus Biosciences, Inc. quarterly EBITDA year-on-year change?
Over the past year, RCUS quarterly EBITDA has changed by +$95.00M (+104.40%)
What is Arcus Biosciences, Inc. TTM EBITDA?
The current TTM EBITDA of RCUS is -$282.00M
What is the all-time high TTM EBITDA for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high TTM EBITDA is $89.95M
What is Arcus Biosciences, Inc. TTM EBITDA year-on-year change?
Over the past year, RCUS TTM EBITDA has changed by -$47.00M (-20.00%)